{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:37:32Z","timestamp":1791351452593,"version":"4.3.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2030939"],"award-info":[{"award-number":["2030939"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001774","name":"University of Sydney","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001774","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>Treatment for advanced cancer entails substantial time commitments, which has been labelled the \u2018time toxicity\u2019 of treatment, though the perspectives of people affected by cancer are still being established. We aimed to establish patient and caregiver perspectives on the \u2018time toxicity\u2019 of palliative systemic treatments.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Semi-structured qualitative interviews were conducted using an inductive approach. Purposively selected adults with advanced gastrointestinal cancers who had received palliative systemic therapy and caregivers were recruited from one metropolitan and regional site. Interviews were analysed using thematic analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Twenty patients and ten caregivers participated. Eighty percent were Australian-born, 60% were 55\u201374\u00a0years old, 57% had colorectal cancer, 50% were female, and 50% were regionally situated. Five themes emerged: (1) treatment as work, (2) opportunity costs of receiving care, (3) treatment time as an investment, (4) time in treatment decision-making, and (5) tools for managing treatment time. Participants found it burdensome to organise their lives around treatment requirements. Perception of time burdens related to understandings of treatment benefit, experience of downsides, and psychological reactions to illness. Time spent coordinating and recovering from treatment had a substantial impact on participants\u2019 lives outside of contact days. However, participants valued the potential benefits of treatment and described healthcare time as a modifier, rather than a driver, of treatment decision-making.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This qualitative analysis contributes a foundational understanding of perceptions, sources, and impacts of healthcare time burdens in an Australian context. Further research will identify, assess, and address modifiable sources of time burdens in cancer care.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00520-025-09621-4","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T06:46:01Z","timestamp":1749537961000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["\u201cThe Cancer is My Life\u201d: patient and caregiver perceptions of the time toxicity of palliative systemic cancer treatments for advanced gastrointestinal cancers"],"prefix":"10.1007","volume":"33","author":[{"given":"Samuel X.","family":"Stevens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella","family":"El-Katateny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"De Abreu Louren\u00e7o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Booth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janette L.","family":"Vardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,10]]},"reference":[{"key":"9621_CR1","unstructured":"2020 AGDoH (2020) Modified Monash model. In: Editor (ed)^(eds) Book Modified Monash model, City"},{"key":"9621_CR2","doi-asserted-by":"publisher","first-page":"e678","DOI":"10.1200\/JOP.19.00328","volume":"16","author":"EM Bange","year":"2020","unstructured":"Bange EM, Doucette A, Gabriel PE, Porterfield F, Harrigan JJ, Wang R, Wojcieszynski AP, Boursi B, Mooney BI, Reiss KA, Mamtani R (2020) Opportunity costs of receiving palliative chemotherapy for metastatic pancreatic ductal adenocarcinoma. JCO Oncol Pract 16:e678\u2013e687","journal-title":"JCO Oncol Pract"},{"key":"9621_CR3","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V (2006) Using thematic analysis in psychology. Qual Res Psychol 3:77\u2013101","journal-title":"Qual Res Psychol"},{"key":"9621_CR4","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1097\/CM9.0000000000003140","volume":"137","author":"W Cao","year":"2022","unstructured":"Cao W, Qin K, Li F (2022) Chen W (2024) Socioeconomic inequalities in cancer incidence and mortality: an analysis of GLOBOCAN. Chin Med J (Engl) 137:1407\u20131413","journal-title":"Chin Med J (Engl)"},{"key":"9621_CR5","doi-asserted-by":"publisher","first-page":"e0300852","DOI":"10.1371\/journal.pone.0300852","volume":"19","author":"AC Dona","year":"2024","unstructured":"Dona AC, Jewett PI, Hwee S, Brown K, Solomon M, Gupta A, Teoh D, Yang G, Wolfson J, Fan Y, Blaes AH, Vogel RI (2024) Logistic burdens of cancer care: a qualitative study. PLoS ONE 19:e0300852","journal-title":"PLoS ONE"},{"key":"9621_CR6","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1200\/JCO.2022.40.28_suppl.236","volume":"40","author":"S Durbin","year":"2022","unstructured":"Durbin S, Lundquist D, Healy M, Lynch K, Bame V, Martin T, Johnson A, Heldreth H, Turbini V, McIntyre C, Juric D, Jimenez R, Nipp RD (2022) Time toxicity in early phase clinical trials (EP-CTs). J Clin Oncol 40:236","journal-title":"J Clin Oncol"},{"key":"9621_CR7","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/1471-2288-13-117","volume":"13","author":"NK Gale","year":"2013","unstructured":"Gale NK, Heath G, Cameron E, Rashid S, Redwood S (2013) Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol 13:117","journal-title":"BMC Med Res Methodol"},{"key":"9621_CR8","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1200\/JCO.21.02810","volume":"40","author":"A Gupta","year":"2022","unstructured":"Gupta A, Eisenhauer EA, Booth CM (2022) The time toxicity of cancer treatment. J Clin Oncol 40:1611\u20131615","journal-title":"J Clin Oncol"},{"issue":"9","key":"9621_CR9","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1093\/oncolo\/oyad128","volume":"28","author":"A Gupta","year":"2023","unstructured":"Gupta A, Hay AE, Crump M, Djurfeldt MS, Zhu L, Cheung MC, Shepherd LE, Chen BE, Booth CM (2023) Contact days associated with cancer treatments in the CCTG LY. 12 trial. Oncologist. 28(9):799\u2013803","journal-title":"Oncologist."},{"key":"9621_CR10","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1200\/OP.2024.20.10_suppl.209","volume":"20","author":"A Gupta","year":"2024","unstructured":"Gupta A, Johnson WV, Ogunleye O, George M, Breininger A, Henderson N, Booth CM, Hanna TP, Rocque GB, Parsons HM, Vogel RI, Blaes AH (2024) It\u2019s like I am always on a leash\u2019\u2019: a multi-stakeholder qualitative analysis of the time toxicity of cancer care. JCO Oncol Pract 20:209\u2013209","journal-title":"JCO Oncol Pract"},{"key":"9621_CR11","doi-asserted-by":"publisher","first-page":"e244278","DOI":"10.1001\/jamanetworkopen.2024.4278","volume":"7","author":"A Gupta","year":"2024","unstructured":"Gupta A, Nguyen P, Kain D, Robinson AG, Kulkarni AA, Johnson DH, Presley CJ, Blaes AH, Rocque GB, Ganguli I, Booth CM, Hanna TP (2024) Trajectories of health care contact days for patients with stage IV non-small cell lung cancer. JAMA Netw Open 7:e244278","journal-title":"JAMA Netw Open"},{"issue":"6","key":"9621_CR12","doi-asserted-by":"publisher","first-page":"e859","DOI":"10.1200\/OP.22.00737","volume":"19","author":"A Gupta","year":"2023","unstructured":"Gupta A, O\u2019Callaghan CJ, Zhu L, Jonker DJ, Wong RP, Colwell B, Moore MJ, Karapetis CS, Tebbutt NC, Shapiro JD, Tu D (2023) Evaluating the time toxicity of cancer treatment in the CCTG CO. 17 trial. JCO Oncol Pract 19(6):e859-66","journal-title":"JCO Oncol Pract"},{"issue":"6","key":"9621_CR13","doi-asserted-by":"publisher","first-page":"e859","DOI":"10.1200\/OP.22.00737","volume":"19","author":"A Gupta","year":"2023","unstructured":"Gupta A, O\u2019Callaghan CJ, Zhu L, Jonker DJ, Wong RP, Colwell B, Moore MJ, Karapetis CS, Tebbutt NC, Shapiro JD, Tu D (2023) Evaluating the time toxicity of cancer treatment in the CCTG CO. 17 trial. JCO Oncol Pract 19(6):e859-66","journal-title":"JCO Oncol Pract"},{"key":"9621_CR14","first-page":"2493","volume":"29","author":"ET Hall","year":"2021","unstructured":"Hall ET, Sridhar D, Singhal S, Fardeen T, Lahijani S, Trivedi R, Gray C, Schapira L (2021) Perceptions of time spent pursuing cancer care among patients, caregivers, and oncology professionals. Support Care Cancer 29:2493\u20132500","journal-title":"Support Care Cancer"},{"key":"9621_CR15","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L, McLeod L, Delacqua G, Delacqua F, Kirby J, Duda SN (2019) The REDCap consortium: building an international community of software platform partners. J Biomed Inform 95:103208","journal-title":"J Biomed Inform"},{"key":"9621_CR16","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009) Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Informa 42:377\u2013381","journal-title":"J Biomed Informa"},{"key":"9621_CR17","unstructured":"Health AIo, Welfare (2021) Cancer in Australia 2021. In: Editor (ed)^(eds) Book Cancer in Australia 2021. AIHW, City"},{"key":"9621_CR18","unstructured":"Howpage S PK, Honeyball F (2018) Assessing the impact of outreach oncology clinics in remote New South Wales. In: Editor (ed)^(eds) Book Assessing the impact of outreach Oncology clinics in remote New South Wales., City"},{"issue":"2","key":"9621_CR19","doi-asserted-by":"publisher","first-page":"e290","DOI":"10.1093\/oncolo\/oyad313","volume":"29","author":"WV Johnson","year":"2023","unstructured":"Johnson WV, Phung QH, Patel VR, Tsai AK, Arora N, Klein MA, Westanmo AD, Blaes AH, Gupta A (2023) Trajectory of healthcare contact days for veterans with advanced gastrointestinal malignancy. Oncol 29(2):e290\u2013e93","journal-title":"Oncol"},{"key":"9621_CR20","doi-asserted-by":"publisher","first-page":"e290","DOI":"10.1093\/oncolo\/oyad313","volume":"29","author":"WV Johnson","year":"2024","unstructured":"Johnson WV, Phung QH, Patel VR, Tsai AK, Arora N, Klein MA, Westanmo AD, Blaes AH, Gupta A (2024) Trajectory of healthcare contact days for veterans with advanced gastrointestinal malignancy. Oncologist 29:e290\u2013e293","journal-title":"Oncologist"},{"key":"9621_CR21","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1200\/JCO.2021.39.3_suppl.398","volume":"39","author":"SA Lim","year":"2021","unstructured":"Lim SA, Hao S, Boyd B, Mitsakos A, Irish W, Parikh AA, Snyder RA (2021) Opportunity costs of undergoingsurgical resection andperioperative chemotherapy forpancreatic adenocarcinoma. J Clin Oncol 39:398","journal-title":"J Clin Oncol"},{"issue":"3","key":"9621_CR22","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/ajr.13102","volume":"32","author":"NJ McPhee","year":"2024","unstructured":"McPhee NJ, Leach M, Nightingale CE, Harris SJ, Segelov E, Ristevski E (2024) Differences in cancer clinical trial activity and trial characteristics at metropolitan and rural trial sites in Victoria, Australia. Australian J Rural Health 32(3):569\u2013581","journal-title":"Australian J Rural Health"},{"key":"9621_CR23","doi-asserted-by":"publisher","first-page":"102046","DOI":"10.1016\/j.esmoop.2023.102046","volume":"8","author":"U Nindra","year":"2023","unstructured":"Nindra U, Shivasabesan G, Childs S, Yoon R, Haider S, Hong M, Cooper A, Roohullah A, Wilkinson K, Pal A, Chua W (2023) Time toxicity associated with early phase clinical trial participation. ESMO Open 8:102046","journal-title":"ESMO Open"},{"key":"9621_CR24","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1177\/17423953211060253","volume":"19","author":"C Nwolise","year":"2023","unstructured":"Nwolise C, Corrie P, Fitzpatrick R, Gupta A, Jenkinson C, Middleton M, Matin R (2023) Burden of cancer trial participation: a qualitative sub-study of the INTERIM feasibility RCT. Chronic Illn 19:81\u201394","journal-title":"Chronic Illn"},{"key":"9621_CR25","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1200\/OP.23.00232","volume":"19","author":"VR Patel","year":"2023","unstructured":"Patel VR, Ramesh V, Tsai AK, Sedhom R, Westanmo AD, Blaes AH, Vogel RI, Parsons HM, Hanna TP, Ganguli I, Dusetzina SB, Rocque GB, Booth CM, Gupta A (2023) Health care contact days experienced by decedents with advanced GI cancer. JCO Oncol Pract 19:1031\u20131038","journal-title":"JCO Oncol Pract"},{"key":"9621_CR26","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/ajr.12921","volume":"31","author":"S Pye","year":"2023","unstructured":"Pye S, Webster E, Zielinski R, Honeyball F (2023) \u2018The best thing since sliced bread\u2019: patient experiences of teleoncology in western NSW. Australian J Rural Health 31:90\u201397","journal-title":"Australian J Rural Health"},{"key":"9621_CR27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1743-7563.2010.01342.x","volume":"7","author":"S Sabesan","year":"2011","unstructured":"Sabesan S, Burgher B, Buettner P, Piliouras P, Otty Z, Varma S, Thaker D (2011) Attitudes, knowledge and barriers to participation in cancer clinical trials among rural and remote patients. Asia Pac J Clin Oncol 7:27\u201333","journal-title":"Asia Pac J Clin Oncol"},{"key":"9621_CR28","unstructured":"Stevens SHF (2020) Patient utilisation of cancer therapies in western New South Wales following introduction of remote video assisted chemotherapy (RVAC). In: Editor (ed)^(eds) Book Patient utilisation of cancer therapies in western New South Wales following introduction of remote video assisted chemotherapy (RVAC), City"},{"key":"9621_CR29","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1186\/s12889-017-4692-y","volume":"17","author":"HE Tervonen","year":"2017","unstructured":"Tervonen HE, Aranda S, Roder D, You H, Walton R, Morrell S, Baker D, Currow DC (2017) Cancer survival disparities worsening by socio-economic disadvantage over the last 3 decades in new South Wales. Australia BMC Public Health 17:691","journal-title":"Australia BMC Public Health"},{"key":"9621_CR30","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J (2007) Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Q Health Care 19:349\u2013357","journal-title":"Int J Q Health Care"},{"key":"9621_CR31","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.mayocpiqo.2023.09.003","volume":"7","author":"C Williams","year":"2023","unstructured":"Williams C, Meyer L, Kawam O, Leventakos K, DeMartino ES (2023) The faces of financial toxicity: a qualitative interview study of financial toxicity in advanced cancer patients in phase I oncology trials. Mayo Clin Proc Innov Qual Outcomes 7:524\u2013533","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"9621_CR32","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/geront\/20.6.649","volume":"20","author":"SH Zarit","year":"1980","unstructured":"Zarit SH, Reever KE, Bach-Peterson J (1980) Relatives of the impaired elderly: correlates of feelings of burden. Gerontologist 20:649\u2013655","journal-title":"Gerontologist"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09621-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-025-09621-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09621-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T18:46:06Z","timestamp":1757184366000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-025-09621-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,10]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["9621"],"URL":"https:\/\/doi.org\/10.1007\/s00520-025-09621-4","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,10]]},"assertion":[{"value":"21 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Sydney Local Health District (Concord Repatriation General Hospital) Human Research Ethics Committee (ETH\/00869) and conducted in accordance with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that human research participants provided informed consent for publication of de-identified statements from interviews.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"564"}}